Ear infection is the second most common condition in dogs. Depending on the part of ear, it can be of three types: otitis externa, otitis media, and otitis interna. Otitis externa and otitis media affect dogs and cats of any breed and age; however, dogs having long ears, such as retrievers and spaniels, and dogs having hairy external canals, such as poodles and terriers, are more susceptible. Otitis externa is a chronic inflammation of external ear canal that causes itching, pain, a strong odor, and muffled hearing in animals. It is caused when there is a change in the normal environment of the ear canal which causes the ear glands lining the canal to enlarge and produce excessive wax. Eventually, the epidermis (an outer skin) and the dermis (inner skin) produce excessive fibrous tissue which results is narrowing of canal.
The global companion animal ear infection treatments market can be segmented based on drug class, route of administration, species, and region. In terms of drug class, the market can be classified into anti-bacterials, anti-yeast, anti-fungal, corticosteroids, and others. The anti-bacterials segment can be categorized into fluoroquinolones, aminoglycosides, and others. Based on route of administration, the global companion animal ear infection treatments market can be divided into otic, topical, oral, and others. In terms of species, the market can be classified into dogs, cats, and others. The global market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
In terms of region, North America accounted for the largest share of the global companion animal ear infection treatments market in terms of revenue in 2017 due to high adoption of companion animals, increase in disposable income, and large number of veterinary clinics in the region. According to the American Pet Products Association’s 2011–2012 National Pet Owners Survey, 62% households, or 72.9 million homes, in the U.S. owned a companion animal (excluding horses). Europe accounted for the second largest market share in 2017 owing to presence of several key players such as Ceva Santé Animale, Merial Animal Health, Virbac, Vetoquinol S.A., and Boehringer Ingelheim, high acceptance of advanced veterinary devices, and large number of pet owners. According to the European Pet Food Industry Federation, over 75 million households in Europe own a pet.
The companion animal ear infection treatments market in Asia Pacific is witnessing strong growth due to increase in pet ownership and spending on companion animals, high research & development activities in animal health, and increase in government expenditure on animal welfare. According to the Animal Health Alliance (Australia) Ltd., almost half i.e., 48% of the population of Australia, would like to either get a pet or get another pet. More than 1.1 million households in the country i.e., 14.9%, planned to get a companion animal in 2013. The high rate of adoption of companion animals is expected to augment the market during the forecast period. Middle East & Africa and Latin America are expected to be prospective markets due to high disposable income and growing pharmaceutical and biotechnology industry.
The global companion animal ear infection treatments market is projected to witness considerable growth during the forecast period. Changes in consumer behavior and increase in pet ownership have led to ‘humanization’ of pets. In the past few years, pets have gained position as member of the owner’s family. This has led to heightened tendency of pet owners to spend more on pet supplies, higher quality food, and expensive medical treatment. Moreover, rise in disposable income of people and changes in lifestyle have resulted in increased expenditure on animals which is expected to augment the market during the forecast period.
Major players operating in the global companion animal ear infection treatments market are Bayer Animal Heath, Elanco, Ceva Santé Animale, Dechra Pharmaceuticals plc, Merck Animal Health, Merial Animal Health, Vetoquinol S.A, Virbac S.A., Vedco, Inc., and Zoetis, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.